MarkWide Research

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 373 8777

24/7 Customer Support

Airway stent market to touch US$ 210 Mn by 2025

Growing minimally invasive surgeries preference for respiratory problems will uplift the airway/lung stent market revenue. The increasing incidences of respiratory disorders associated with lung cancer have led to increased adoption of minimally invasive surgeries to avoid pain and incisions. Besides, minimally invasive surgeries are increasingly being preferred to treat patients with congenital cystic adenomatoid malformations that caused difficulty in breathing. Therefore, an airway stent is utilized to facilitate breathing in such patients. Moreover, airway stent placement is cost-effective compared to surgeries and has reduced the risk of complications, further augmenting airway stent demand. Following these promising developments, the Global Airway Stent Market is estimated to see healthy growth, pegged at a CAGR of around 6% throughout the forecast period 2020-2025.

The ongoing COVID-19 pandemic is an unparalleled public health concern and has a minimal impact on the airway stent market. Healthcare professionals worldwide have postponed the minimally invasive surgeries to decline the risk of patients being exposed to COVID-19 in hospitals, thereby supporting the hospitals in converting operating theatres into intensive care units.

Rising minimally invasive surgeries preference will augment the market growth

Rising minimally invasive surgeries preference for respiratory problems will fuel the airway stent market demand. Patients undergoing minimally invasive respiratory conditions experience faster recovery, fewer complications, shorter hospital stays, and reduced blood loss. As a result, bronchoscopy, a non-surgical minimally invasive procedure for stent placement, is being widely adopted at an incredible pace, thereby uplifting the demand for airway stents. Several advancements in minimally invasive procedures also augment the number of people preferring minimally invasive techniques to treat breathing problems.

The growing incidences of lung cancer have led to the increasing adoption of minimally invasive surgeries to circumvent pain. Patients with congenital cystic adenomatoid malformations causing difficulty in breathing prefer undergoing stent placement. Therefore, the utilization of airway stents is significantly increasing, and as a result, the demand for airway stents is expanding. Moreover, airway stent placement is cost-effective compared to conventional procedures and has reduced the risk of complications.

Sector Overview

An airway stent is an endobronchial prosthesis of different materials supporting and preserving the hollow tubular airway structure’s patency. An airway stent may prevent the extension of a tumor into the airway, help in the healing or control of airway fistulas, or help the airway wall against failure or external concentration. Stents can be manufactured with various materials, such as silicone or metal, and can vary in multiple sizes and shapes. They can be permanent or momentary. Airway stenting is shown in a combination of benign and malignant processes. Independent of the sign, before any stent placement, the thoracic surgeon or interventional pulmonologist must ensure that the sufferer does not have any surgically revocable airway disease. Stenting may involve or preclude surgery in some cases, significantly when it extends the lesion to >4 cm in length, a generally used limit for tracheal resection.

Segmentation Overview of the Global Airway Stent Market

The airway stent market is segmented based on Product, Device Type, Material, Patient, and End-use. These major market segments are further categorized into various sub-segments to study the market in detail.

By Product Outlook

  • Tracheal Stents
  • Bronchial Stents
  • Laryngeal Stents

By Device Type Outlook

  • Self-Expandable
  • Balloon-Expandable

By Material Outlook

  • Metal
  • Stainless
  • Nitinol
  • Silicone
  • Hybrid

By Patient Outlook

  • Adult
  • Pediatric

By End-use Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Key Players Insights

Boston Scientific Corporation, Micro-Tech (Nanjing) Co., Ltd., Hood laboratories, Novatech SA, Merit Medical Systems, Inc., Cook Group, EFER Endoscopy, and Stening SRL, among others, are the prominent airway stent companies included during the research study.

Leave a Comment

Y